Publication
Influence of P53 on the radiotherapy response of hepatocellular carcinoma
dc.contributor.author | Gomes, AR | |
dc.contributor.author | Abrantes, AM | |
dc.contributor.author | Brito, AF | |
dc.contributor.author | Laranjo, M | |
dc.contributor.author | Casalta-Lopes, JE | |
dc.contributor.author | Gonçalves, AC | |
dc.contributor.author | Sarmento-Ribeiro, AB | |
dc.contributor.author | Botelho, MF | |
dc.contributor.author | Tralhão, JG | |
dc.date.accessioned | 2016-05-11T15:58:18Z | |
dc.date.available | 2016-05-11T15:58:18Z | |
dc.date.issued | 2015-09 | |
dc.description.abstract | Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, and it has a poor prognosis and few therapeutic options. Radiotherapy is one of the most effective forms of cancer treatment, and P53 protein is one of the key molecules determining how a cell responds to radiotherapy. The aim of this study was to determine the therapeutic efficacy of iodine-131 in three human HCC cell lines. | pt_PT |
dc.identifier.citation | Clin Mol Hepatol. 2015 Sep;21(3):257-67. | pt_PT |
dc.identifier.doi | 10.3350/cmh.2015.21.3.257 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.4/1898 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.subject | Carcinoma Hepatocelular | pt_PT |
dc.subject | Proteína Supressora de Tumor p53 | pt_PT |
dc.title | Influence of P53 on the radiotherapy response of hepatocellular carcinoma | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |